Compound Profile: Minoxytop 5% Healing Pharma
Minoxidil 5% is a topical vasodilator and potassium channel opener extensively researched for its effects on peripheral blood circulation and hair follicle physiology. Originally developed as an antihypertensive agent, minoxidil demonstrates unique properties in dermal tissue research, particularly regarding follicular metabolism and angiogenesis. This compound operates through multiple mechanisms including potassium channel modulation and vascular endothelial growth factor (VEGF) expression enhancement in cell culture studies. Researchers at Stroid UK Shop investigate minoxidil’s role in understanding hair cycle biology and dermal vascularisation pathways.
Research Applications
Laboratory investigations examine minoxidil’s capacity to modulate dermal blood flow through direct smooth muscle relaxation and nitric oxide pathway activation. Studies demonstrate increased prostaglandin E2 synthesis in follicular dermal papilla cells, suggesting involvement in hair cycle regulation mechanisms. Researchers analyse minoxidil’s effects on adenosine metabolism, particularly its inhibition of lysyl hydroxylase activity, which influences collagen cross-linking in dermal matrix studies. The compound shows promise in hair products research for understanding androgenetic patterns and follicular miniaturisation processes. Additional investigations focus on minoxidil’s anti-fibrotic properties and potential applications in wound healing research models.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Concentration | 5% w/v Minoxidil |
| Formulation | Topical solution |
| Manufacturer | Healing Pharma |
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | Dermal circulation, follicle biology |
This research-grade formulation enables controlled studies examining dose-response relationships in dermal tissue models. Laboratories utilising compounds from our SARMs and peptides categories often investigate synergistic pathways between growth factors and vasodilatory mechanisms in tissue engineering applications.
Research Compliance Statement
Minoxytop 5% is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. This product requires proper laboratory licensing and should only be used by qualified research personnel in controlled laboratory environments for approved research applications.
